Difference between revisions of "Ziprasidone"

From Psychiatrienet
Jump to: navigation, search
 
(7 intermediate revisions by 2 users not shown)
Line 1: Line 1:
 
{{Drug
 
{{Drug
 
| name = Ziprasidone
 
| name = Ziprasidone
 +
| type = Antipsychotic
 
| group = Atypical AP
 
| group = Atypical AP
 +
| otheruse = Moodstabilizer
 
| pubchem = 60854
 
| pubchem = 60854
| half =
 
 
| medscape = 20568
 
| medscape = 20568
 
| emea =  
 
| emea =  
| therapy1 =
+
| ftk = -
| therapyid1 =
+
| metabolization = * Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.
| therapyname1 =
+
| metabolization_ref = <ref>Bazire S; Psychotropic drug directory, 2007</ref>
| therapy2 =
+
| <includeonly> isswitch=1</includeonly>
| therapyid2 =
 
| therapyname2 =
 
| ftk =  
 
| othername1 =
 
| other1 =
 
| otherid1 =
 
| other2 =
 
| otherid2 =  
 
| othername2 =  
 
| type = Antipsychotic
 
 
}}
 
}}
<noinclude>[[Category:Drug]]</noinclude>
 

Latest revision as of 13:56, 15 June 2010

Ziprasidone
Type Antipsychotic
Group Atypical AP
Other use Moodstabilizer
links
Medscape Ziprasidone
PubChem 60854
PubMed Ziprasidone
Wikipedia Ziprasidone

Ziprasidone is a Antipsychotic in the group Atypical AP. Ziprasidone is also used as Moodstabilizer.


Metabolization
  • Ziprasidone is metabolized by CYP1A2 (minor) and CYP3A4.[1]


  1. Bazire S; Psychotropic drug directory, 2007